Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

PHASE3CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Impetigo
Interventions
DRUG

ozenoxacin placebo

cream

DRUG

retapamulin 1% ointment

ointment

DRUG

ozenoxacin 1% cream

1% cream

Trial Locations (19)

Unknown

Georg Popp, Augsburg

Klaus Chelius, Cologne

Roland Aschoff, Dresden

Diamant Thaci, Frankfurt am Main

Stephan Schilling, Mahlow

Ismail Mitha, Benoni

Johan Lombaard, Bloemfontein

Jan Fourie, Dundee

Dawie Kruger, George

Philip Nel, Hatfield

Essack Mitha, Johannesburg

J Trokis, Kraaifontein

Mohammed Tayob, Middelburg

Mashra Gani, Port Elizabeth

Zelda Punt, Port Elizabeth

Molefe Phayane, Pretoria

Gail Todd, Rondebosch

Yacoob Vahed, Welkom

Christo van Dyk, Worcester

All Listed Sponsors
lead

Ferrer Internacional S.A.

INDUSTRY

NCT01397461 - Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo | Biotech Hunter | Biotech Hunter